Madam Speaker, I recall that early in the pandemic, times were very difficult across the country and around the world. At the time, we needed to ensure that all options were on the table. That is why we entered into agreements with several companies to create any kind of vaccine, because it was impossible to know at that time which vaccine would work for the population. That is why it was important to try all the options, and that is what we are talking about here today.
In the House of Commons on November 3rd, 2023. See this statement in context.